Literature DB >> 26423403

The potential role of the NEK6, AURKA, AURKB, and PAK1 genes in adenomatous colorectal polyps and colorectal adenocarcinoma.

Elmas Kasap1, Emre Gerceker2, Seda Örenay Boyacıoglu3, Hakan Yuceyar2, Hatice Yıldırm3, Semin Ayhan4, Mehmet Korkmaz3.   

Abstract

Colorectal adenomatous polyp (CRAP) is a major risk factor for the development of sporadic colorectal cancer (CRC). Histone modifications are one of the epigenetic mechanisms that may have key roles in the carcinogenesis of CRC. The objective of the present study is to investigate the alternations in the defined histone modification gene expression profiles in patients with CRAP and CRC. Histone modification enzyme key gene expressions of the CRC, CRAP, and control groups were evaluated and compared using the reverse transcription PCR (RT-PCR) array method. Gene expression analysis was performed in the CRAP group after dividing the patients into subgroups according to the polyp diameter, pathological results, and morphological parameters which are risk factors for developing CRC in patients with CRAP. PAK1, NEK6, AURKA, AURKB, HDAC1, and HDAC7 were significantly more overexpressed in CRC subjects compared to the controls (p < 0.05). PAK1, NEK6, AURKA, AURKB, and HDAC1 were significantly more overexpressed in the CRAP group compared to the controls (p < 0.005). There were no significant differences between the CRAP and CRC groups with regards to PAK1, NEK6, AURKA, or AURKB gene overexpression. PAK1, NEK6, AURKA, and AURKB were significantly in correlation with the polyp diameter as they were more overexpressed in polyps with larger diameters. In conclusion, overexpressions of NEK6, AURKA, AURKB, and PAK1 genes can be used as predictive markers to decide the colonoscopic surveillance intervals after the polypectomy procedure especially in polyps with larger diameters.

Entities:  

Keywords:  AURKA; AURKB; Colorectal adenocarcinoma; Colorectal adenomatous polyp; Epigenetic; Histone modification; NEK6; PAK1

Mesh:

Substances:

Year:  2015        PMID: 26423403     DOI: 10.1007/s13277-015-4131-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  35 in total

Review 1.  The many ways of Wnt in cancer.

Authors:  Paul Polakis
Journal:  Curr Opin Genet Dev       Date:  2007-02       Impact factor: 5.578

Review 2.  Epigenetic therapy of cancer: past, present and future.

Authors:  Christine B Yoo; Peter A Jones
Journal:  Nat Rev Drug Discov       Date:  2006-01       Impact factor: 84.694

3.  Aurora kinase A in Barrett's carcinogenesis.

Authors:  Massimo Rugge; Matteo Fassan; Giovanni Zaninotto; Marco Pizzi; Luciano Giacomelli; Giorgio Battaglia; Christian Rizzetto; Paola Parente; Ermanno Ancona
Journal:  Hum Pathol       Date:  2010-07-24       Impact factor: 3.466

4.  DNA methylation biomarker candidates for early detection of colon cancer.

Authors:  Joo Mi Yi; Mashaal Dhir; Angela A Guzzetta; Christine A Iacobuzio-Donahue; Kyu Heo; Kwang Mo Yang; Hiromu Suzuki; Minoru Toyota; Hwan-Mook Kim; Nita Ahuja
Journal:  Tumour Biol       Date:  2012-01-12

Review 5.  Ulcerative colitis and cancer.

Authors:  Mahmoud N Kulaylat; Merril T Dayton
Journal:  J Surg Oncol       Date:  2010-06-15       Impact factor: 3.454

6.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

Review 7.  The colorectal adenoma-carcinoma sequence.

Authors:  A Leslie; F A Carey; N R Pratt; R J C Steele
Journal:  Br J Surg       Date:  2002-07       Impact factor: 6.939

Review 8.  Inflammatory bowel disease and colon cancer.

Authors:  Noor Jawad; Natalie Direkze; Simon J Leedham
Journal:  Recent Results Cancer Res       Date:  2011

9.  Colorectal polyps and polyposis syndromes.

Authors:  Noam Shussman; Steven D Wexner
Journal:  Gastroenterol Rep (Oxf)       Date:  2014-01-23

10.  HDAC up-regulation in early colon field carcinogenesis is involved in cell tumorigenicity through regulation of chromatin structure.

Authors:  Yolanda Stypula-Cyrus; Dhwanil Damania; Dhananjay P Kunte; Mart Dela Cruz; Hariharan Subramanian; Hemant K Roy; Vadim Backman
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

View more
  10 in total

1.  Expression profiles of histone modification genes in gastric cancer progression.

Authors:  Seda Orenay-Boyacioglu; Elmas Kasap; Emre Gerceker; Hakan Yuceyar; Ufuk Demirci; Fahri Bilgic; Mehmet Korkmaz
Journal:  Mol Biol Rep       Date:  2018-09-24       Impact factor: 2.316

2.  Transcriptional landscape of human cancers.

Authors:  Mengyuan Li; Qingrong Sun; Xiaosheng Wang
Journal:  Oncotarget       Date:  2017-05-23

3.  Identification of differentially expressed genes in the development of osteosarcoma using RNA-seq.

Authors:  Yihao Yang; Ya Zhang; Xin Qu; Junfeng Xia; Dongqi Li; Xiaojuan Li; Yu Wang; Zewei He; Su Li; Yonghong Zhou; Lin Xie; Zuozhang Yang
Journal:  Oncotarget       Date:  2016-12-27

4.  Circulating cell-free nucleosomes as biomarkers for early detection of colorectal cancer.

Authors:  Louise Rasmussen; Ib Jarle Christensen; Marielle Herzog; Jake Micallef; Hans Jørgen Nielsen
Journal:  Oncotarget       Date:  2017-10-20

Review 5.  In Mitosis You Are Not: The NIMA Family of Kinases in Aspergillus, Yeast, and Mammals.

Authors:  Scott Bachus; Drayson Graves; Lauren Fulham; Nikolas Akkerman; Caelan Stephanson; Jessica Shieh; Peter Pelka
Journal:  Int J Mol Sci       Date:  2022-04-06       Impact factor: 5.923

6.  Feasibility of Unbiased RNA Profiling of Colorectal Tumors: A Proof of Principle.

Authors:  Vardit Moshayoff; Ouriel Faktor; Luigi Laghi; Giuseppe Celesti; Tamar Peretz; Dan Keret; Dana Cohen; Eran Israeli
Journal:  PLoS One       Date:  2016-07-21       Impact factor: 3.240

7.  Ubiquitination and regulation of AURKA identifies a hypoxia-independent E3 ligase activity of VHL.

Authors:  E Hasanov; G Chen; P Chowdhury; J Weldon; Z Ding; E Jonasch; S Sen; C L Walker; R Dere
Journal:  Oncogene       Date:  2017-01-23       Impact factor: 8.756

Review 8.  Checking NEKs: Overcoming a Bottleneck in Human Diseases.

Authors:  Andressa Peres de Oliveira; Luidy Kazuo Issayama; Isadora Carolina Betim Pavan; Fernando Riback Silva; Talita Diniz Melo-Hanchuk; Fernando Moreira Simabuco; Jörg Kobarg
Journal:  Molecules       Date:  2020-04-13       Impact factor: 4.411

9.  Expression of the NEK family in normal and cancer tissue: an immunohistochemical study.

Authors:  Talita Diniz Melo-Hanchuk; Mariana Bonjiorno Martins; Lucas Leite Cunha; Fernando Augusto Soares; Laura Sterian Ward; José Vassallo; Jörg Kobarg
Journal:  BMC Cancer       Date:  2020-01-06       Impact factor: 4.430

10.  Control of clathrin-mediated endocytosis by NIMA family kinases.

Authors:  Braveen B Joseph; Yu Wang; Phil Edeen; Vladimir Lažetić; Barth D Grant; David S Fay
Journal:  PLoS Genet       Date:  2020-02-18       Impact factor: 5.917

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.